At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 260 enrolled
Drug / intervention
Clonidine Gel 0.1% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
In Brief
A Phase 2 clinical trial evaluating Clonidine Gel 0.1% and Placebo for Painful Diabetic Neuropathy and 2 related conditions. Completed, enrolled 260 participants across 23 sites.
Detailed Summary
The purpose of the study is to determine whether clonidine gel is an effective treatment for reducing the pain associated with painful diabetic neuropathy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPainful Diabetic Neuropathy, Diabetic Neuropathy, Neuropathy
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 2014
Enrollment StartMar 2014
Primary CompletionMar 2015
TodayJul 2026
First PostedFeb 20, 2014
Enrollment StartMar 1, 2014
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 12.4 years ago
Interventions
Clonidine Gel 0.1%drug
Placebodrug